J0457Injection, aztreonam, 100 mg
Published CMS Medicare Part B payment-limit context for J0457, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.
CMS payment limit
$2.271
per 100 MG · Medicare Part B
Down 0.7%from $2.288 in 2026-Q2
- Current quarter
- Billing unit
Payment limit over time
$2.7617$1.8773
2024-Q4: $1.974; 2025-Q1: $2.071; 2025-Q2: $2.478; 2025-Q3: $2.665; 2025-Q4: $2.533; 2026-Q1: $2.233; 2026-Q2: $2.288; 2026-Q3: $2.271
No current FDA shortage matchThe latest completed FDA data has no affected record matching the Aztreonam ingredient family (FDA data as of August 20, 2026).
Azactam
Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.
Put another code on your radar.
Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.